Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Systimmune Inc.
Sponsor

Systimmune Inc.

United States 15318 Northeast 95th Street, 98052-2517, United States

About the sponsor

Clinical research activity is centered on cancer, with attention to advanced solid tumors and metastatic disease. The sponsor’s trial portfolio reflects interest in difficult-to-treat malignancies, including non-small cell lung cancer and other solid tumors.

  • Non-small cell lung cancer
  • Metastatic solid tumors
  • Unresectable malignancies
  • Anticancer therapeutics

Research sites across multiple countries support the evaluation of therapies aimed at tumor control in advanced disease settings.

About Specializations

Systimmune Inc. runs clinical trials in conditions such as Small cell lung cancer, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

1 clinical trial

Small cell lung cancer

Not yet recruiting

A Phase 3 Trial of BL-M14D1 and Atezolizumab vs Standard Therapy in First‑Line Extensive‑Stage Small Cell Lung Cancer Patients

Registered drugNo placebo
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Atezolizumab
  • Sponsor:Systimmune Inc.

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.